2020 RESEARCH
- Archives -Robert Finberg details next steps for COVID vaccine
Robert W. Finberg, MD, a member of Gov. Charlie Baker’s COVID-19 Vaccine Advisory Group, explains the process of getting the population vaccinated that will play out in phases over the coming year.
Protein commonly screened for in pregnancy is linked to gestational diabetes
New research by Silvia Corvera, MD, and Tiffany Moore Simas, MD, MPH, MEd, show that low levels of a protein commonly seen in screening tests for chromosomal disorders is associated with adipose tissue remodeling, glucose resistance and gestational diabetes mellitus in pregnant women.
NIH research funding surges at UMass Medical School
National Institutes of Health research funding to UMass Medical School grew by 78 percent for the first quarter of fiscal 2021, which began July 1. Grants and contracts from all funding sources increased by nearly 50 percent.
New study co-authored by MD/PhD student Benjamin Helfand shows frequent delirium in older COVID patients
MD/PhD student Benjamin Helfand is co-first author on a study published in the Journal of American Medical Association Network Open that examines the frequency of COVID-19 positive older adults presenting to the emergency department with delirium.
UMass Medical School postdoctoral fellow Anna Loveland named STAT Wunderkind
UMass Medical School postdoctoral fellow Anna Loveland, PhD, has been named a STAT Wunderkind by the health and science media company STAT. STAT Wunderkinds honors the brightest young minds in life science for their work in academia, industry, and in the clinic.
Women in Science: Ana Maldonado-Contreras pivots gut microbiome studies to tackle COVID-19
Ana Maldonado-Contreras, PhD, studies the gut microbiome and chronic disease, in particular inflammatory bowel disease, and is now working to understand how gut microbes can predispose patients to severe COVID complications.
Pincus Medalist Marsha Moses delivers annual scientific lecture at UMass Medical School
Biochemist Marsha Moses, PhD, accepted the 30th Gregory Pincus Medal of the Worcester Foundation for Biomedical Research and UMass Medical School and delivered the annual Pincus Memorial Lecture on Tuesday, Nov. 10.
Scientists sequence genomes of 240 animals to understand evolution at DNA level
A multidisciplinary team of scientists led by Elinor Karlsson, PhD, has captured biodiversity at a genetic level, according to a new study published in Nature.
FDA clears IND application for Tay-Sachs gene therapy
Axovant Gene Therapies, a clinical-stage company developing innovative gene therapies based on UMass Medical School research discoveries, has announced that the FDA has lifted its clinical hold and cleared Axovant’s Investigational New Drug application to initiate a registrational study of gene therapy to treat patients with Tay-Sachs disease and Sandhoff disease.
COVID-19 vaccine trial reports high effectiveness; UMass Medical School key enrollment site
First results from a Pfizer and BioNTech Phase III messenger RNA COVID-19 vaccine trial, in which UMass Medical School is participating, show promising findings, with more than 90 percent effectiveness in preventing infection with the SARS-CoV-2 virus, the companies announced.